Long-Term Ocrelizumab Data Show Benefit in Relapsing Multiple Sclerosis
Recorded Courses
hosted byProjects In Knowledge Inc. (PIK)
hosted byProjects In Knowledge Inc. (PIK)
attend it anywhere online
category
Medicine
Neurology
price
Free
Long-Term Ocrelizumab Data Show Benefit in Relapsing Multiple Sclerosis is organized by Projects In Knowledge Inc. (PIK).
Release Date: May 01, 2023
Termination Date: Apr 30, 2024
Activity Goal:
The goal of this CME/CE activity is to provide comprehensive and up-to-date information on the best practices in multiple sclerosis
Learning Objective(s):
• Appraise recent clinical efficacy and safety evidence for available and emerging DMTs for MS management.
Additional details will be posted as soon as information is available.